Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Anti-PD-1 and Anti-PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes.

Mellati M, Eaton KD, Brooks-Worrell BM, Hagopian WA, Martins R, Palmer JP, Hirsch IB.

Diabetes Care. 2015 Sep;38(9):e137-8. doi: 10.2337/dc15-0889. Epub 2015 Jun 26. No abstract available.

PMID:
26116720
2.

Impact of islet autoimmunity on the progressive β-cell functional decline in type 2 diabetes.

Brooks-Worrell BM, Boyko EJ, Palmer JP.

Diabetes Care. 2014 Dec;37(12):3286-93. doi: 10.2337/dc14-0961. Epub 2014 Sep 19.

3.

Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes.

Brooks-Worrell BM, Iyer D, Coraza I, Hampe CS, Nalini R, Ozer K, Narla R, Palmer JP, Balasubramanyam A.

Diabetes Care. 2013 Dec;36(12):4098-103. doi: 10.2337/dc12-2328. Epub 2013 Oct 15.

4.

Islet autoimmunity in phenotypic type 2 diabetes patients.

Brooks-Worrell B, Narla R, Palmer JP.

Diabetes Obes Metab. 2013 Sep;15 Suppl 3:137-40. doi: 10.1111/dom.12167. Review.

5.

Prevention versus intervention of type 1 diabetes.

Brooks-Worrell B, Palmer JP.

Clin Immunol. 2013 Dec;149(3):332-8. doi: 10.1016/j.clim.2013.05.018. Epub 2013 Jun 10. Review.

PMID:
23803322
6.

Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmune type 2 diabetes patients.

Brooks-Worrell BM, Palmer JP.

Clin Exp Immunol. 2013 Feb;171(2):164-70. doi: 10.1111/cei.12012.

7.

Rosiglitazone treatment does not decrease amyloid deposition in transplanted islets from transgenic mice expressing human islet amyloid polypeptide.

Udayasankar J, Zraika S, Aston-Mourney K, Subramanian SL, Brooks-Worrell BM, Taborsky GJ, Hull RL.

Transplant Proc. 2013 Mar;45(2):574-9. doi: 10.1016/j.transproceed.2012.05.079. Epub 2012 Sep 25.

8.

Biomarkers and immune-modulating therapies for type 2 diabetes.

Brooks-Worrell B, Narla R, Palmer JP.

Trends Immunol. 2012 Nov;33(11):546-53. doi: 10.1016/j.it.2012.07.002. Epub 2012 Aug 14. Review.

PMID:
22897868
9.
10.

Comparison of cryopreservation methods on T-cell responses to islet and control antigens from type 1 diabetic patients and controls.

Brooks-Worrell B, Tree T, Mannering SI, Durinovic-Bello I, James E, Gottlieb P, Wong S, Zhou Z, Yang L, Cilio CM, Reichow J, Menart B, Rutter R, Schreiner R, Pham M, Petrich de Marquesini L, Lou O, Scotto M, Mallone R, Schloot NC; T-Cell Workshop Committee, Immunology of Diabetes Society.

Diabetes Metab Res Rev. 2011 Nov;27(8):737-45. doi: 10.1002/dmrr.1245.

PMID:
22069253
11.

Immunology of Diabetes Society T-Cell Workshop: HLA class II tetramer-directed epitope validation initiative.

James EA, Mallone R, Schloot NC, Gagnerault MC, Thorpe J, Fitzgerald-Miller L, Reichow J, Wagner R, Pham MN, Jospe N, Lou O, Gottlieb PA, Brooks-Worrell BM, Durinovic-Belló I; T-Cell Workshop Committee, Immunology of Diabetes Society.

Diabetes Metab Res Rev. 2011 Nov;27(8):727-36. doi: 10.1002/dmrr.1244.

PMID:
22069252
12.

Is diabetes mellitus a continuous spectrum?

Brooks-Worrell B, Palmer JP.

Clin Chem. 2011 Feb;57(2):158-61. doi: 10.1373/clinchem.2010.148270. Epub 2010 Nov 10. Review.

13.

Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society.

Mallone R, Mannering SI, Brooks-Worrell BM, Durinovic-Belló I, Cilio CM, Wong FS, Schloot NC; T-Cell Workshop Committee, Immunology of Diabetes Society.

Clin Exp Immunol. 2011 Jan;163(1):33-49. doi: 10.1111/j.1365-2249.2010.04272.x. Epub 2010 Oct 5. Review.

14.

Identification of autoantibody-negative autoimmune type 2 diabetic patients.

Brooks-Worrell BM, Reichow JL, Goel A, Ismail H, Palmer JP.

Diabetes Care. 2011 Jan;34(1):168-73. doi: 10.2337/dc10-0579. Epub 2010 Sep 20.

15.

Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes.

Mannering SI, Wong FS, Durinovic-Belló I, Brooks-Worrell B, Tree TI, Cilio CM, Schloot NC, Mallone R; Immunology of Diabetes Society T-Cell Workshop Committee.

Clin Exp Immunol. 2010 Nov;162(2):197-209. doi: 10.1111/j.1365-2249.2010.04237.x. Epub 2010 Sep 15. Review.

16.

Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity.

Ortqvist E, Brooks-Worrell B, Lynch K, Radtke J, Bekris LM, Kockum I, Agardh CD, Cilio CM, Lethagen AL, Persson B, Lernmark A, Reichow J, Oak S, Palmer JP, Hampe CS.

J Clin Endocrinol Metab. 2010 Nov;95(11):E310-8. doi: 10.1210/jc.2010-0785. Epub 2010 Aug 4.

17.

Parenteral insulin suppresses T cell proliferation to islet antigens.

Greenbaum CJ, McCulloch-Olson M, Chiu HK, Palmer JP, Brooks-Worrell B.

Pediatr Diabetes. 2011 May;12(3 Pt 1):150-5. doi: 10.1111/j.1399-5448.2010.00674.x.

18.

Latent autoimmune diabetes in adults.

Naik RG, Brooks-Worrell BM, Palmer JP.

J Clin Endocrinol Metab. 2009 Dec;94(12):4635-44. doi: 10.1210/jc.2009-1120. Epub 2009 Oct 16. Review.

PMID:
19837918
19.

Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.

Rother KI, Spain LM, Wesley RA, Digon BJ 3rd, Baron A, Chen K, Nelson P, Dosch HM, Palmer JP, Brooks-Worrell B, Ring M, Harlan DM.

Diabetes Care. 2009 Dec;32(12):2251-7. doi: 10.2337/dc09-0773. Epub 2009 Oct 6.

20.

Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes.

Herold KC, Brooks-Worrell B, Palmer J, Dosch HM, Peakman M, Gottlieb P, Reijonen H, Arif S, Spain LM, Thompson C, Lachin JM; Type 1 Diabetes TrialNet Research Group.

Diabetes. 2009 Nov;58(11):2588-95. doi: 10.2337/db09-0249. Epub 2009 Aug 12.

21.

Improved T cell assay for identification of type 1 diabetes patients.

Brooks-Worrell B, Warsen A, Palmer JP.

J Immunol Methods. 2009 May 15;344(1):79-83. doi: 10.1016/j.jim.2009.03.004. Epub 2009 Mar 26.

PMID:
19328805
22.
23.

Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients.

Chiu HK, Tsai EC, Juneja R, Stoever J, Brooks-Worrell B, Goel A, Palmer JP.

Diabetes Res Clin Pract. 2007 Aug;77(2):237-44. Epub 2007 Jan 17.

PMID:
17234296
24.

Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study.

Seyfert-Margolis V, Gisler TD, Asare AL, Wang RS, Dosch HM, Brooks-Worrell B, Eisenbarth GS, Palmer JP, Greenbaum CJ, Gitelman SE, Nepom GT, Bluestone JA, Herold KC.

Diabetes. 2006 Sep;55(9):2588-94.

25.

Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age?

Palmer JP, Hampe CS, Chiu H, Goel A, Brooks-Worrell BM.

Diabetes. 2005 Dec;54 Suppl 2:S62-7. Review.

26.

Autoimmunity and clinical course in children with type 1, type 2, and type 1.5 diabetes.

Gilliam LK, Brooks-Worrell BM, Palmer JP, Greenbaum CJ, Pihoker C.

J Autoimmun. 2005 Nov;25(3):244-50. Epub 2005 Oct 21.

PMID:
16243484
27.

Precursor frequencies of T-cells reactive to insulin in recent onset type 1 diabetes mellitus.

Naik RG, Beckers C, Wentwoord R, Frenken A, Duinkerken G, Brooks-Worrell B, Schloot NC, Palmer JP, Roep BO.

J Autoimmun. 2004 Aug;23(1):55-61.

PMID:
15236753
28.

Autoimmunity to islet proteins in children diagnosed with new-onset diabetes.

Brooks-Worrell BM, Greenbaum CJ, Palmer JP, Pihoker C.

J Clin Endocrinol Metab. 2004 May;89(5):2222-7.

PMID:
15126545
29.
30.

Intermolecular antigen spreading occurs during the preclinical period of human type 1 diabetes.

Brooks-Worrell B, Gersuk VH, Greenbaum C, Palmer JP.

J Immunol. 2001 Apr 15;166(8):5265-70.

31.

Peripheral blood mononuclear cell responses from type 1 diabetic patients and subjects at-risk for type 1 diabetes to human fetal pancreatic tissue proteins.

Brooks-Worrell BM, Peterson KP, Peterson CM, Palmer JP, Jovanovic L.

Transplantation. 2000 May 15;69(9):1907-12.

PMID:
10830230
32.

Reactivation of type 1 diabetes in patients receiving human fetal pancreatic tissue transplants without immunosuppression.

Brooks-Worrell BM, Peterson KP, Peterson CM, Palmer JP, Jovanovic L.

Transplantation. 2000 May 15;69(9):1824-9.

PMID:
10830218
33.

Reactivation of type 1 diabetes in patients receiving human fetal pancreatic tissue transplants without immunosuppression.

Brooks-Worrell BM, Peterson KP, Peterson CM, Palmer JP, Jovanovic L.

Transplantation. 2000 Jan 15;69(1):166-72.

PMID:
10653397
34.

Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients.

Brooks-Worrell BM, Juneja R, Minokadeh A, Greenbaum CJ, Palmer JP.

Diabetes. 1999 May;48(5):983-8.

PMID:
10331401
35.

Insulin autoantibodies and insulin antibodies have similar binding characteristics.

Brooks-Worrell BM, Nielson D, Palmer JP.

Proc Assoc Am Physicians. 1999 Jan-Feb;111(1):92-6.

PMID:
9893161
36.

Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins.

Brooks-Worrell BM, Starkebaum GA, Greenbaum C, Palmer JP.

J Immunol. 1996 Dec 15;157(12):5668-74.

PMID:
8955220
37.

Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression.

Mehta VK, Hao W, Brooks-Worrell BM, Palmer JP.

Eur J Endocrinol. 1994 Feb;130(2):208-14.

PMID:
8130898
38.

The functional state of the beta cell modulates IL-1 and TNF-induced cytotoxicity.

Mehta V, Hao W, Brooks-Worrell BM, Palmer JP.

Lymphokine Cytokine Res. 1993 Aug;12(4):255-9.

PMID:
8218598

Supplemental Content

Loading ...
Support Center